NINA STATILE: Open Payments
NPI 1144746793 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 14 payments from 7 companies in 2025. Trend: 2023 $900 · 2024 $694 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 7 | $219 |
| GENZYME CORPORATION | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Amgen Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: NEFFY, DUPIXENT, Rhapsido, TEZSPIRE, AIRSUPRA, NUCALA.
Industry payments across NY — which companies pay providers there.
